\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ none\ \(204\)\
\-\ multiple\\ lytic\\ lesions\\ expanding\\ the\\ cortex\\ with\\ endosteal\\ scalloping\\ and\\ linear\\ lucencies\\ without\\ soft\\ tissue\\ mass\\ or\\ periosteal\\ reaction\\.\ \(0\)\
\-\ ollier\\'s\\ disease\\,\\ enchondromatosis\ \(0\)\
\-\ chondrosarcoma\ \(79\)\
\-\ nonossifying\\ fibroma\ \(10\)\
\-\ fibrous\\ dysplasia\ \(50\)\
\-\ langerhans\\ cell\\ histiocytosis\ \(1\)\
\-\ bone\\ infarct\ \(20\)\
\-\ simple\\ bone\\ cyst\ \(7\)\
\-\ 3\\ year\\ old\\ evaluate\\ for\\ fracture\ \(1\)\
\-\ this\\ disease\\ is\\ named\\ after\\ louis\\ l\\?opold\\ ollier\\ a\\ french\\ surgeon\\ famous\\ for\\ his\\ work\\ in\\ orthopedic\\ and\\ reconstructive\\ surgery\\ in\\ late\\ 1800\\'s\\.\\ \ \(0\)\
\-\ enchondromatosis\\ most\\ frequently\\ involves\\ the\\ short\\ tubular\\ bones\\ of\\ hands\\ and\\ feet\\ as\\ well\\ as\\ long\\ bones\\ of\\ upper\\ and\\ lower\\ extremities\\.\\ \\ this\\ is\\ a\\ nonhereditary\\ abnormality\\ with\\ one\\ side\\ affected\\ more\\ severely\\.\\ lesion\\ growth\\ stabilizes\\ at\\ puberty\\.\\ most\\ lesions\\ are\\ metaphyseal\\ or\\ diaphyseal\\ however\\ there\\ can\\ be\\ growth\\ disturbance\\ if\\ the\\ lesion\\ involves\\ the\\ growth\\ plate\\.\ \(0\)\
\-\ debated\\ amount\\ of\\ increased\\ risk\\ for\\ chondrosarcoma\\;\\ however\\,\\ in\\ an\\ adult\\ long\\ bone\\ with\\ pain\\ and\\ no\\ evidence\\ of\\ fracture\\ malignancy\\ should\\ be\\ considered\\ until\\ proven\\ otherwise\\.\ \(0\)\
\-\ enchondromatosis\\ with\\ multiple\\ soft\\ tissue\\ hemangiomas\\ is\\ termed\\ maffucci\\â\\€\\™s\\ syndrome\\.\\ this\\ is\\ unilateral\\ and\\ involves\\ the\\ hands\\ and\\ feet\\,\\ and\\ carries\\ an\\ increased\\ risk\\ of\\ malignant\\ transformation\\ compared\\ to\\ ollier\\â\\€\\™s\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ollier\\:\\ 0\\.09283023366096477\ \(0\)\
\-\ enchondromatosis\\:\\ 0\\.09172962021313721\ \(0\)\
\-\ involves\\:\\ 0\\.0589801683788303\ \(0\)\
\-\ growth\\:\\ 0\\.05518295043775692\ \(0\)\
\-\ hands\\:\\ 0\\.04377296306231742\ \(0\)\
\-\ opold\\:\\ 0\\.043641180316665834\ \(0\)\
\-\ famous\\:\\ 0\\.043641180316665834\ \(0\)\
\-\ 1800\\:\\ 0\\.043641180316665834\ \(0\)\
\-\ nonhereditary\\:\\ 0\\.043641180316665834\ \(0\)\
\-\ feet\\:\\ 0\\.04329571452946714\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.042299243977193014\ \(0\)\
\-\ stabilizes\\:\\ 0\\.038202505620289054\ \(0\)\
\-\ bones\\:\\ 0\\.03570328981311958\ \(0\)\
\-\ debated\\:\\ 0\\.03567366589867524\ \(0\)\
\-\ maffucci\\:\\ 0\\.03567366589867524\ \(0\)\
\-\ french\\:\\ 0\\.03400796175698607\ \(0\)\
\-\ named\\:\\ 0\\.032242244212734916\ \(0\)\
\-\ bone\\:\\ 0\\.03153615863554262\ \(0\)\
\-\ reconstructive\\:\\ 0\\.03094341122032159\ \(0\)\
\-\ risk\\:\\ 0\\.030645610369891947\ \(0\)\
\-\ diaphyseal\\:\\ 0\\.03057654007104574\ \(0\)\
\-\ puberty\\:\\ 0\\.030234991202298455\ \(0\)\
\-\ disturbance\\:\\ 0\\.030234991202298455\ \(0\)\
\-\ carries\\:\\ 0\\.030234991202298455\ \(0\)\
\-\ long\\:\\ 0\\.02917051000824479\ \(0\)\
\-\ louis\\:\\ 0\\.02856928706060928\ \(0\)\
\-\ termed\\:\\ 0\\.028338989953505853\ \(0\)\
\-\ nonossifying\\:\\ 0\\.02790824056246808\ \(0\)\
\-\ expanding\\:\\ 0\\.027511989534381266\ \(0\)\
\-\ endosteal\\:\\ 0\\.027145118385105416\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.026331736943069395\ \(0\)\
\-\ scalloping\\:\\ 0\\.02604044733899547\ \(0\)\
\-\ severely\\:\\ 0\\.025765349065951848\ \(0\)\
\-\ lucencies\\:\\ 0\\.025379400840854265\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.025287393461836196\ \(0\)\
\-\ metaphyseal\\:\\ 0\\.02525716018446629\ \(0\)\
\-\ langerhans\\:\\ 0\\.025021377763727405\ \(0\)\
\-\ s\\:\\ 0\\.02426502640707512\ \(0\)\
\-\ proven\\:\\ 0\\.024080567848440943\ \(0\)\
\-\ transformation\\:\\ 0\\.02398626985353652\ \(0\)\
\-\ however\\:\\ 0\\.023558099560367033\ \(0\)\
\-\ fibroma\\:\\ 0\\.02353997729415881\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.02353997729415881\ \(0\)\
\-\ lesions\\:\\ 0\\.022649113924197502\ \(0\)\
\-\ surgeon\\:\\ 0\\.02253880468774843\ \(0\)\
\-\ fracture\\:\\ 0\\.022307666636364146\ \(0\)\
\-\ late\\:\\ 0\\.022010250353957806\ \(0\)\
\-\ plate\\:\\ 0\\.02120256896442199\ \(0\)\
\-\ adult\\:\\ 0\\.02120256896442199\ \(0\)\
\-\ unilateral\\:\\ 0\\.020994096264668888\ \(0\)\
\-\ simple\\:\\ 0\\.02084330810880399\ \(0\)\
\-\ disease\\:\\ 0\\.02074362684973818\ \(0\)\
\-\ increased\\:\\ 0\\.020697869126729263\ \(0\)\
\-\ soft\\:\\ 0\\.020603235287064852\ \(0\)\
\-\ orthopedic\\:\\ 0\\.020194653344415853\ \(0\)\
\-\ periosteal\\:\\ 0\\.02006606182756803\ \(0\)\
\-\ tissue\\:\\ 0\\.020053675133193997\ \(0\)\
\-\ short\\:\\ 0\\.019940726144477488\ \(0\)\
\-\ work\\:\\ 0\\.019818485488089507\ \(0\)\
\-\ tubular\\:\\ 0\\.01969919067829218\ \(0\)\
\-\ most\\:\\ 0\\.019533021205228478\ \(0\)\
\-\ l\\:\\ 0\\.019284839099694917\ \(0\)\
\-\ reaction\\:\\ 0\\.01921309153879112\ \(0\)\
\-\ lytic\\:\\ 0\\.018936068500929513\ \(0\)\
\-\ infarct\\:\\ 0\\.01877048466891199\ \(0\)\
\-\ \\'s\\:\\ 0\\.0186539269145252\ \(0\)\
\-\ until\\:\\ 0\\.018578828668017484\ \(0\)\
\-\ frequently\\:\\ 0\\.018334310077277007\ \(0\)\
\-\ affected\\:\\ 0\\.01830457728489972\ \(0\)\
\-\ cortex\\:\\ 0\\.018101302597782025\ \(0\)\
\-\ linear\\:\\ 0\\.01793347313404103\ \(0\)\
\-\ compared\\:\\ 0\\.017906046498518183\ \(0\)\
\-\ multiple\\:\\ 0\\.01781986142058682\ \(0\)\
\-\ amount\\:\\ 0\\.01766581362280204\ \(0\)\
\-\ lesion\\:\\ 0\\.017233220059410442\ \(0\)\
\-\ fibrous\\:\\ 0\\.017100129991371647\ \(0\)\
\-\ evaluate\\:\\ 0\\.017100129991371647\ \(0\)\
\-\ considered\\:\\ 0\\.017076942618537854\ \(0\)\
\-\ dysplasia\\:\\ 0\\.016698518383389628\ \(0\)\
\-\ extremities\\:\\ 0\\.016592508014558853\ \(0\)\
\-\ \\?\\:\\ 0\\.016509304458537162\ \(0\)\
\-\ malignancy\\:\\ 0\\.0163469786029778\ \(0\)\
\-\ abnormality\\:\\ 0\\.015606722494210655\ \(0\)\
\-\ n\\/a\\:\\ 0\\.015322805184945974\ \(0\)\
\-\ malignant\\:\\ 0\\.015290448892966838\ \(0\)\
\-\ otherwise\\:\\ 0\\.015194629868447253\ \(0\)\
\-\ side\\:\\ 0\\.014655675751307282\ \(0\)\
\-\ this\\:\\ 0\\.014274315049219798\ \(0\)\
\-\ should\\:\\ 0\\.013486180900439603\ \(0\)\
\-\ be\\:\\ 0\\.013047096270731971\ \(0\)\
\-\ as\\:\\ 0\\.012797797088060671\ \(0\)\
\-\ his\\:\\ 0\\.012192519938846198\ \(0\)\
\-\ syndrome\\:\\ 0\\.012098547409577434\ \(0\)\
\-\ an\\:\\ 0\\.011699652121630988\ \(0\)\
\-\ if\\:\\ 0\\.011478927890003146\ \(0\)\
\-\ one\\:\\ 0\\.011464016749062595\ \(0\)\
\-\ cell\\:\\ 0\\.011426934215749932\ \(0\)\
\-\ cyst\\:\\ 0\\.01136817394072328\ \(0\)\
\-\ is\\:\\ 0\\.011134470859103478\ \(0\)\
\-\ evidence\\:\\ 0\\.011091299917657811\ \(0\)\
\-\ for\\:\\ 0\\.010828338841228443\ \(0\)\
\-\ more\\:\\ 0\\.01058008073916914\ \(0\)\
\-\ none\\:\\ 0\\.010493660925287161\ \(0\)\
\-\ surgery\\:\\ 0\\.010272272595842945\ \(0\)\
\-\ upper\\:\\ 0\\.010208319333508506\ \(0\)\
\-\ \\;\\:\\ 0\\.010026837566596999\ \(0\)\
\-\ without\\:\\ 0\\.009960461219594853\ \(0\)\
\-\ or\\:\\ 0\\.009916066821422848\ \(0\)\
\-\ 3\\:\\ 0\\.009905819439141286\ \(0\)\
\-\ can\\:\\ 0\\.009595160160737968\ \(0\)\
\-\ well\\:\\ 0\\.009569707687963619\ \(0\)\
\-\ lower\\:\\ 0\\.009514168660217141\ \(0\)\
\-\ after\\:\\ 0\\.008752481201035656\ \(0\)\
\-\ and\\:\\ 0\\.007129069533949246\ \(0\)\
\-\ there\\:\\ 0\\.0062956215666583595\ \(0\)\
\-\ in\\:\\ 0\\.006258374705053291\ \(0\)\
\-\ mass\\:\\ 0\\.0058834703314235865\ \(0\)\
\-\ are\\:\\ 0\\.005766702339255454\ \(0\)\
\-\ at\\:\\ 0\\.0057315007565922425\ \(0\)\
\-\ pain\\:\\ 0\\.005166377066983835\ \(0\)\
\-\ year\\:\\ 0\\.004733194402341162\ \(0\)\
\-\ old\\:\\ 0\\.004331359390407201\ \(0\)\
\-\ no\\:\\ 0\\.004259624508434663\ \(0\)\
\-\ \\,\\:\\ 0\\.004020446517583476\ \(0\)\
\-\ a\\:\\ 0\\.00392673071107526\ \(0\)\
\-\ the\\:\\ 0\\.0034220119976145\ \(0\)\
\-\ of\\:\\ 0\\.0028837574454947633\ \(0\)\
\-\ with\\:\\ 0\\.0023169143780176187\ \(0\)\
\-\ to\\:\\ 0\\.002114198556648447\ \(0\)\
\-\ \\.\\:\\ 0\\.001581662499386715\ \(0\)\
